149 related articles for article (PubMed ID: 33777094)
1. NPC2 as a Prognostic Biomarker for Glioblastoma Based on Integrated Bioinformatics Analysis and Cytological Experiments.
Wei D; Shen S; Lin K; Lu F; Zheng P; Wu S; Kang D
Front Genet; 2021; 12():611442. PubMed ID: 33777094
[TBL] [Abstract][Full Text] [Related]
2. Exploration of NPC2 as a Potential Biomarker for Immunotherapy Using RNA-seq and Protein Data - A New Hypothesis.
Lu W; Li D; Tao F; Chen Q; Fan S; Ma Y; Dong H; Hu Y; Yue C
Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1340-1353. PubMed ID: 37056065
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.
Zeng C; Xing W; Liu Y
J Cell Biochem; 2019 Aug; 120(8):12489-12499. PubMed ID: 30816613
[TBL] [Abstract][Full Text] [Related]
5. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
7. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH
CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
Oncol Lett; 2021 Jan; 21(1):22. PubMed ID: 33240428
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
10. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
11. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
12. [Experimental studies on correlation between nucleolus spindle-related protein 1 and the malignant progression and prognosis of human glioblastoma multiforme].
Xue YP; Ji XY; Yang L; Liu HR; Sheng YJ; Dai XX; Xi YJ; Liu JC; Shi J; Xie T; Zhang YS; Ma JW; Dong J
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(5):340-345. PubMed ID: 29429243
[No Abstract] [Full Text] [Related]
13. Transcription factor 7 functions as an unfavorable prognostic marker of glioblastoma multiforme by promoting proliferation by upregulating c-Myc.
Su Y; Wang Y; Sun Y; Zhou X
Neuroreport; 2018 Jun; 29(9):745-752. PubMed ID: 29642232
[TBL] [Abstract][Full Text] [Related]
14. MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma.
Chen W; Huang B; Wang E; Wang X
Onco Targets Ther; 2019; 12():3099-3107. PubMed ID: 31114250
[No Abstract] [Full Text] [Related]
15. Identification of novel LncRNA targeting Smad2/PKCα signal pathway to negatively regulate malignant progression of glioblastoma.
Tang C; Wang Y; Zhang L; Wang J; Wang W; Han X; Mu C; Gao D
J Cell Physiol; 2020 Apr; 235(4):3835-3848. PubMed ID: 31603255
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 is Related to Cell Proliferation in Neuronal Tissue: An Integrated Analysis of Bioinformatics and Experiments.
Yu Y; Sung SK; Lee CH; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Kim GH; Heo HJ; Lee H; Kim TW; Lee Y; Myung K; Oh CK; Kim YH
Front Genet; 2021; 12():743786. PubMed ID: 34646310
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
[TBL] [Abstract][Full Text] [Related]
18. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
19. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
20. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
